135 related articles for article (PubMed ID: 29988132)
1. Searching for Alzheimer's disease therapies.
Stower H
Nat Med; 2018 Jul; 24(7):894-897. PubMed ID: 29988132
[No Abstract] [Full Text] [Related]
2. Lost in Translation? Finding Our Way To Effective Alzheimer's Disease Therapies.
Quinn JF
J Alzheimers Dis; 2018; 64(s1):S33-S39. PubMed ID: 29758942
[TBL] [Abstract][Full Text] [Related]
3. Alzheimer's disease, dementia, and stem cell therapy.
Duncan T; Valenzuela M
Stem Cell Res Ther; 2017 May; 8(1):111. PubMed ID: 28494803
[TBL] [Abstract][Full Text] [Related]
4. Aβ immunotherapy for Alzheimer's disease: where are we?
Güell-Bosch J; Montoliu-Gaya L; Esquerda-Canals G; Villegas S
Neurodegener Dis Manag; 2016 Jun; 6(3):179-81. PubMed ID: 27230296
[No Abstract] [Full Text] [Related]
5. Immunization therapy in Alzheimer's disease.
Mor F; Monsonego A
Expert Rev Neurother; 2006 May; 6(5):653-9. PubMed ID: 16734513
[TBL] [Abstract][Full Text] [Related]
6. Neurobiology. Untangling Alzheimer's by paring plaques bolsters amyloid theory.
Beckman M
Science; 2004 Aug; 305(5685):762. PubMed ID: 15297635
[No Abstract] [Full Text] [Related]
7. Alzheimer's disease: Moving towards a vaccine.
Holtzman DM
Nature; 2008 Jul; 454(7203):418-20. PubMed ID: 18650906
[No Abstract] [Full Text] [Related]
8. Immunology and immunotherapy of Alzheimer's disease.
Weiner HL; Frenkel D
Nat Rev Immunol; 2006 May; 6(5):404-16. PubMed ID: 16639431
[TBL] [Abstract][Full Text] [Related]
9. Is there still any hope for amyloid-based immunotherapy for Alzheimer's disease?
Panza F; Logroscino G; Imbimbo BP; Solfrizzi V
Curr Opin Psychiatry; 2014 Mar; 27(2):128-37. PubMed ID: 24445401
[TBL] [Abstract][Full Text] [Related]
10. Mixed dementia in clinical trials of Alzheimer's disease.
Massoud F
Can J Neurol Sci; 2012 Sep; 39(5):566-7. PubMed ID: 22931693
[No Abstract] [Full Text] [Related]
11. What We Learn from the CTAD (Clinical Trials Alzheimer's Disease) 2018.
Vellas B; Aisen P; Weiner M; Touchon J
J Prev Alzheimers Dis; 2018; 5(4):214-215. PubMed ID: 30298178
[No Abstract] [Full Text] [Related]
12. Novel recruitment models will drive Alzheimer's trial success.
Vidoni ED; Bothwell RJ; Burns JM; Dwyer JR
Alzheimers Dement; 2018 Jan; 14(1):117-119. PubMed ID: 29156221
[No Abstract] [Full Text] [Related]
13. Amyloid beta peptide immunotherapy in Alzheimer disease.
Delrieu J; Ousset PJ; Voisin T; Vellas B
Rev Neurol (Paris); 2014 Dec; 170(12):739-48. PubMed ID: 25459121
[TBL] [Abstract][Full Text] [Related]
14. Potential use of nerve growth factor to treat Alzheimer's disease.
Science; 1989 Jan; 243(4887):11. PubMed ID: 2643155
[No Abstract] [Full Text] [Related]
15. Antibody therapy for Alzheimer's disease.
Morgan D
Expert Rev Vaccines; 2003 Feb; 2(1):53-9. PubMed ID: 12901597
[TBL] [Abstract][Full Text] [Related]
16. Editorial: Alzheimer's Disease Drug Development Pipeline 2020.
Sabbagh MN
J Prev Alzheimers Dis; 2020; 7(2):66-67. PubMed ID: 32236392
[No Abstract] [Full Text] [Related]
17. Current and emerging therapies for Alzheimer's disease.
Nygaard HB
Clin Ther; 2013 Oct; 35(10):1480-9. PubMed ID: 24139420
[TBL] [Abstract][Full Text] [Related]
18. Preventing Alzheimer's disease is difficult.
Launer LJ
Lancet Neurol; 2015 Sep; 14(9):872-4. PubMed ID: 26293557
[No Abstract] [Full Text] [Related]
19. Lessons Learned from Alzheimer Disease: Clinical Trials with Negative Outcomes.
Cummings J
Clin Transl Sci; 2018 Mar; 11(2):147-152. PubMed ID: 28767185
[No Abstract] [Full Text] [Related]
20. Genentech's Alzheimer's antibody trial to study disease prevention.
Garber K
Nat Biotechnol; 2012 Aug; 30(8):731-2. PubMed ID: 22871696
[No Abstract] [Full Text] [Related]
[Next] [New Search]
